Omori Hisamitsu, Yoshimoto Daisuke, Kumar Maya, Goren Amir
a Department of Biomedical Laboratory Sciences, Faculty of Life Sciences , Kumamoto University , Kumamoto , Japan.
b Medical Affairs, Development and Medical Affairs , GlaxoSmithKline K.K ., Tokyo , Japan.
Expert Rev Pharmacoecon Outcomes Res. 2016 Aug;16(4):501-12. doi: 10.1586/14737167.2016.1104250. Epub 2015 Oct 23.
We examined the prevalence of chronic obstructive pulmonary disease (COPD) diagnosed and at-risk status, and public awareness of COPD among adults in Japan, as well as respondent characteristics and health outcomes compared with controls.
Regression models used 2012 National Health and Wellness Survey in Japan data to compare COPD-diagnosed, at-risk, and healthy adults (aged ≥18) on demographics, health behaviors, health-related quality of life (HRQoL), productivity and healthcare resource use.
Among n = 29,978 respondents, diagnosed COPD prevalence was 0.9%; 26.9% were at-risk. Relative to controls, those at-risk and diagnosed with COPD had significantly greater healthcare resource use, with lower productivity and HRQoL. Fewer than 20% of respondents were aware of COPD.
Over 25% of adult Japanese respondents were at-risk for COPD and had health outcomes impairments relative to controls. Efforts to increase awareness among the general public are needed.
我们调查了日本成年人中慢性阻塞性肺疾病(COPD)的诊断患病率及风险状态,以及公众对COPD的认知情况,并将受访者特征和健康结果与对照组进行了比较。
回归模型使用2012年日本国民健康与福祉调查数据,比较已诊断为COPD、有患病风险和健康的成年人(年龄≥18岁)在人口统计学、健康行为、健康相关生活质量(HRQoL)、生产力和医疗资源使用方面的情况。
在n = 29,978名受访者中,已诊断的COPD患病率为0.9%;26.9%有患病风险。与对照组相比,有患病风险和已诊断为COPD的人群医疗资源使用显著更多,生产力和HRQoL更低。知晓COPD的受访者不到20%。
超过25%的日本成年受访者有患COPD的风险,且相对于对照组,其健康结果受损。需要努力提高公众意识。